Emerging retatrutide, a twin -action treatment targeting equally GLP-1 and GIP receptors, is generating considerable interest within the healthcare community. Initial clinical studies have shown significant reductions in body mass and improvements in health markers for individuals with obesity . Scientists believe this novel approach may mark a … Read More